Overview

Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The objectives of the study are to obtain knowledge about the safety in use, the patients' general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter (OTC) setting.
Details
Lead Sponsor:
Nycomed
Treatments:
Bromides
Ipratropium
Xylometazoline